Top Banner
Defining the Expectations of Your Center’s Leaders Cancer Center Administrators’ Forum April 2011
16

Defining the Expectations of Your Center’s Leaders Cancer Center Administrators’ Forum April 2011.

Dec 26, 2015

Download

Documents

Patience Fox
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Defining the Expectations of Your Center’s Leaders Cancer Center Administrators’ Forum April 2011.

Defining the Expectationsof Your Center’s Leaders

Cancer Center Administrators’ ForumApril 2011

Page 2: Defining the Expectations of Your Center’s Leaders Cancer Center Administrators’ Forum April 2011.

Cancer Center Leadership Roles

Cancer Center Director: this role is usually well defined both by the NCI CCSG guidelines and by the institution­ Vision/strategic planning - Budget­ Recruitment - Fundraising­ Equivalent to departmental chair - Space

Deputy Director, Associate Directors, Program Leaders and Shared Resource Directors­ Often times the authority, expectations and responsibilities

of these positions are ill defined

Page 3: Defining the Expectations of Your Center’s Leaders Cancer Center Administrators’ Forum April 2011.

Today’s Presentations

Associate Director Role­ Anita Harrison, Hollings Cancer Center, MUSC­ Melanie Thomas, Associate Director of

Clinical Investigations

Program Leader Role­ Kimberly Kerstann, Winship Cancer Institute, Emory­ Paula Vertino, Cancer Genetics & Epigenetics

Program Leader

Shared Resource Director Role­ Stephen Long, Greenebaum Cancer Center, U of Maryland­ Nicholas Ambulos, Director of Shared Services

Page 4: Defining the Expectations of Your Center’s Leaders Cancer Center Administrators’ Forum April 2011.

Associate Director

Common Cancer Center Associate Director Positions­ Basic Science - Prevention & Control­ Clinical Investigations - Cancer Disparities­ Translational Research - Administration­ Shared Resources - Clinical Affairs­ Education

Generally, these positions are considered the Center’s “Senior Leadership” and report to the Director or Deputy Director

Typically, they receive CCSG support for 10-20% effort; total Center support can be up to 50%

Meet 1-2 times a month as a group with Director/Deputy

Page 5: Defining the Expectations of Your Center’s Leaders Cancer Center Administrators’ Forum April 2011.

Associate Directors

Formulate priorities, strategies and provide input into the allocation of resources

Closely monitor the strength of several of the CCSG Essential Characteristics (cancer focus, research facilities, inter/transdisciplinary interactions, organizational capabilities) across the Center

Evaluate Center’s progress in meeting strategic planning goals

Expected to be inter-connected with other departmental/college/campus-wide efforts to build synergy with the Cancer Center

Page 6: Defining the Expectations of Your Center’s Leaders Cancer Center Administrators’ Forum April 2011.

Defining the Associate Director’s Role

Create a job description for each

Role should be distinct from other roles but clarify any areas of overlap and make sure that these are well articulated­ Associate Director (Breadth) vs Program Leader (Depth)

Define what financial resources they have to accomplish their job and/or what part of the Center’s budget are they accountable for

Effectiveness should be annually reviewed (peer review by other Associate Directors and Program Leaders; EAB)

Page 7: Defining the Expectations of Your Center’s Leaders Cancer Center Administrators’ Forum April 2011.

Associate Director of Clinical Investigations

Melanie B. Thomas, MDAssociate Professor of Medicine

Grace E. DeWolff Chair in GI Oncology

Recruited in 2008 from University of Texas M.D. Anderson Cancer Center

Nationally-recognized for her multidisciplinary clinical research program in hepatobiliary cancer

2009 NCI Clinical Leadership Team Award

Cancer Center supports 30% effort for this role

Page 8: Defining the Expectations of Your Center’s Leaders Cancer Center Administrators’ Forum April 2011.

Authorities and Responsibilities

Page 9: Defining the Expectations of Your Center’s Leaders Cancer Center Administrators’ Forum April 2011.

Authorities and Responsibilities

Identify clinical research expertise needed and work with Director and institutional leaders (dept, divisions) to facilitate faculty recruitment

Integrate investigators into multidisciplinary groups in which they are actively engaged with basic and population based researchers in developing translational research

Page 10: Defining the Expectations of Your Center’s Leaders Cancer Center Administrators’ Forum April 2011.

Cancer Genes & Molecular Regulation

Lipid Signaling in

Cancer

Developmental Cancer

Therapeutics

Cancer Immunology

HCC Research Programs

Clinical and Laboratory Interface

TRANSLATIONAL RESEARCH

H&N GUBreast Thoracic

Established Disease-based Research Groups with Key Clinical Faculty

Hem/Mal

BakerJenretteKramer

Christiansen

DayGillespie

ShiraiSharma

ReedDenlingerSilvestriSimon

KraftDrabkinKeane

Golshayan

StuartKraveka

HudspethCosta

Neuro

GiglioPatel

GI

ThomasEsnaola

ChinCamp

CancerPrevention& Control

Page 11: Defining the Expectations of Your Center’s Leaders Cancer Center Administrators’ Forum April 2011.

Authorities and Responsibilities

Promotion of investigator initiated trials, especially with Center’s pre-clinical investigators

Develop consortium relationships with NCI Phase I and Phase II awardees as well as industry partners to develop and conduct novel trials

Promotion and facilitation of the development of leadership within cooperative groups

Increase clinical trial accrual; work with Associate Director of Cancer Disparities to promote minority participation

Page 12: Defining the Expectations of Your Center’s Leaders Cancer Center Administrators’ Forum April 2011.

Strategies Employed

ExPERT – junior clinical investigators meet monthly with Dr. Thomas and invited shared resource directors and program leaders to discuss correlative science concepts

Pfizer 3D Program (Sept 2010)

Disease & Program Retreats 10 in 2010

Abney Clinical Scholars – HCC salary support for new junior faculty for protected time (Graybill, Young)

Ongoing faculty recruitment – 2010 HCC further investing in CTO to support accrual/protocol development (VA, East

Cooper, Phase I)

Page 13: Defining the Expectations of Your Center’s Leaders Cancer Center Administrators’ Forum April 2011.

Shifting the Portfolio Toward IITs

IITs11%

Cooperative Group66%

Industry 20%

Other Peer Reviewed

3%

Other Peer Reviewed

2%Industry

24%

Cooperative Group

51%

IITs23%

HCC Active Therapeutic Studies by Sponsor

2008(N=122)

2011(N=126)

2 Active Phase I Trials in 2008 10 Active Phase I Trials in 2011

Page 14: Defining the Expectations of Your Center’s Leaders Cancer Center Administrators’ Forum April 2011.

15 by 2015The Next Breakthrough Could Be Yours

• Less than 1% of adults in SC diagnosed with cancer enroll on a therapeutic clinical trial

• 254 patients (12.4% of new patients) enrolled onto a therapy trial at the HCC in 2010

• HCC led statewide public policy changes in 2010 to ensure every person with insurance has access to cancer clinical trials

• The HCC goal is to increase enrollment to therapy trials to 15% by 2015

Page 15: Defining the Expectations of Your Center’s Leaders Cancer Center Administrators’ Forum April 2011.

• Goals: - Raise everyone's awareness of clinical trials

- Integrate clinical trials into all standard pt care practices

- Foster culture that values and promotes faculty/staff involvement in clinical trials

• Strategies: - Continual rounding with faculty/staff about clinical trials - Identify and knock down ALL barriers to enrolling - Visuals: banners (12), posters (80), buttons, info cards - Commitment by MUSC leadership to hold faculty/staff accountable for growth in clinical trials

15 by 2015The Next Breakthrough Could Be Yours

Page 16: Defining the Expectations of Your Center’s Leaders Cancer Center Administrators’ Forum April 2011.

15 by 2015The Next Breakthrough Could Be Yours

HCC Therapeutic Accrual to Cancer Clinical Trials(assumes a 3% growth in overall pt volume/year)